会員登録
ログイン
【4572】カルナバイオサイエンス
創薬支援。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/11/08 | Q3予 | 925 | → | 0.0% | 0.0% | -2,201 | → | 0.0% | 0.0% | -2,208 | → | 0.0% | -0.3% | -2,225 | → | 0.0% | 0.0% |
| 2024.12 | 2024/08/07 | Q2予 | 925 | → | 0.0% | 0.0% | -2,201 | → | 0.0% | 0.0% | -2,208 | → | 0.0% | -0.3% | -2,225 | → | 0.0% | 0.0% |
| 2024.12 | 2024/05/10 | Q1予 | 925 | → | 0.0% | 0.0% | -2,201 | → | 0.0% | 0.0% | -2,208 | ↓ | -0.3% | -0.3% | -2,225 | → | 0.0% | 0.0% |
| 2024.12 | 2024/02/09 | 当初予 | 925 | - | - | - | -2,201 | - | - | - | -2,201 | - | - | - | -2,225 | - | - | - |
| 2023.12 | 2024/02/09 | 実 | 1,625 | ↑ | +0.9% | +80.2% | -1,116 | ↑ | +5.7% | +41.0% | -1,126 | ↑ | +6.4% | +40.4% | -1,152 | ↑ | +6.3% | +40.5% |
| 2023.12 | 2023/12/14 | 修正予 | 1,610 | ↑ | +78.5% | +78.5% | -1,183 | ↑ | +37.4% | +37.4% | -1,203 | ↑ | +37.0% | +36.3% | -1,229 | ↑ | +36.5% | +36.5% |
| 2023.12 | 2023/11/07 | Q3予 | 902 | → | 0.0% | 0.0% | -1,890 | → | 0.0% | 0.0% | -1,911 | → | 0.0% | -1.1% | -1,936 | → | 0.0% | 0.0% |
| 2023.12 | 2023/08/07 | Q2予 | 902 | → | 0.0% | 0.0% | -1,890 | → | 0.0% | 0.0% | -1,911 | → | 0.0% | -1.1% | -1,936 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/10 | Q1予 | 902 | → | 0.0% | 0.0% | -1,890 | → | 0.0% | 0.0% | -1,911 | ↓ | -1.1% | -1.1% | -1,936 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/10 | 当初予 | 902 | - | - | - | -1,890 | - | - | - | -1,890 | - | - | - | -1,936 | - | - | - |
| 2022.12 | 2023/02/10 | 実 | 1,386 | ↑ | +1.7% | +23.0% | -1,269 | ↑ | +12.5% | +26.6% | -1,278 | ↑ | +11.9% | +26.1% | -1,349 | ↑ | +10.8% | +25.0% |
| 2022.12 | 2022/12/14 | 修正予 | 1,363 | ↑ | +14.9% | +20.9% | -1,451 | ↑ | +13.2% | +16.1% | -1,451 | ↑ | +13.9% | +16.1% | -1,513 | ↑ | +13.0% | +15.9% |
| 2022.12 | 2022/11/07 | Q3予 | 1,186 | → | 0.0% | +5.2% | -1,672 | → | 0.0% | +3.4% | -1,685 | → | 0.0% | +2.6% | -1,740 | → | 0.0% | +3.3% |
| 2022.12 | 2022/08/05 | Q2予 | 1,186 | → | 0.0% | +5.2% | -1,672 | → | 0.0% | +3.4% | -1,685 | → | 0.0% | +2.6% | -1,740 | → | 0.0% | +3.3% |
| 2022.12 | 2022/05/10 | Q1予 | 1,186 | ↑ | +5.2% | +5.2% | -1,672 | ↑ | +3.4% | +3.4% | -1,685 | ↑ | +2.6% | +2.6% | -1,740 | ↑ | +3.3% | +3.3% |
| 2022.12 | 2022/02/10 | 当初予 | 1,127 | - | - | - | -1,730 | - | - | - | -1,730 | - | - | - | -1,799 | - | - | - |
| 2021.12 | 2022/02/10 | 実 | 2,017 | ↑ | +0.5% | +118.5% | -531 | ↑ | +3.1% | +70.7% | -522 | ↑ | +5.4% | +71.2% | -534 | ↑ | +4.6% | +70.7% |
| 2021.12 | 2021/12/23 | 修正予 | 2,006 | ↑ | +117.3% | +117.3% | -548 | ↑ | +69.7% | +69.7% | -552 | ↑ | +69.6% | +69.5% | -560 | ↑ | +69.3% | +69.3% |
| 2021.12 | 2021/11/08 | Q3予 | 923 | → | 0.0% | 0.0% | -1,811 | → | 0.0% | 0.0% | -1,816 | → | 0.0% | -0.3% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/08/06 | Q2予 | 923 | → | 0.0% | 0.0% | -1,811 | → | 0.0% | 0.0% | -1,816 | ↓ | -0.3% | -0.3% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/05/10 | Q1予 | 923 | → | 0.0% | 0.0% | -1,811 | → | 0.0% | 0.0% | -1,811 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/12 | 当初予 | 923 | - | - | - | -1,811 | - | - | - | -1,811 | - | - | - | -1,825 | - | - | - |
| 2020.12 | 2021/02/12 | 実 | 1,133 | ↑ | +2.7% | +9.4% | -1,057 | ↑ | +11.2% | +40.6% | -1,077 | ↑ | +10.4% | +39.5% | -1,111 | ↑ | +9.6% | +39.0% |
| 2020.12 | 2020/12/08 | 修正予 | 1,103 | ↑ | +6.5% | +6.5% | -1,190 | ↑ | +33.1% | +33.1% | -1,202 | ↑ | +33.0% | +32.4% | -1,229 | ↑ | +32.5% | +32.5% |
| 2020.12 | 2020/11/09 | Q3予 | 1,036 | → | 0.0% | 0.0% | -1,779 | → | 0.0% | 0.0% | -1,794 | → | 0.0% | -0.8% | -1,822 | → | 0.0% | 0.0% |
| 2020.12 | 2020/08/07 | Q2予 | 1,036 | → | 0.0% | 0.0% | -1,779 | → | 0.0% | 0.0% | -1,794 | ↓ | -0.8% | -0.8% | -1,822 | → | 0.0% | 0.0% |
| 2020.12 | 2020/05/12 | Q1予 | 1,036 | → | 0.0% | 0.0% | -1,779 | → | 0.0% | 0.0% | -1,779 | → | 0.0% | 0.0% | -1,822 | → | 0.0% | 0.0% |
| 2020.12 | 2020/02/07 | 当初予 | 1,036 | - | - | - | -1,779 | - | - | - | -1,779 | - | - | - | -1,822 | - | - | - |
| 2019.12 | 2020/02/07 | 実 | 3,207 | ↑ | +0.0% | +158.6% | 977 | ↑ | +0.9% | +158.9% | 957 | ↑ | +0.6% | +157.3% | 828 | ↑ | +4.7% | +148.9% |
| 2019.12 | 2020/01/09 | 修正予 | 3,206 | ↑ | +5.5% | +158.5% | 968 | ↑ | +209.3% | +158.4% | 951 | ↑ | +240.9% | +156.9% | 791 | ↑ | +269.6% | +146.7% |
| 2019.12 | 2019/11/08 | Q3予 | 3,038 | → | 0.0% | +145.0% | 313 | → | 0.0% | +118.9% | 279 | → | 0.0% | +116.7% | 214 | → | 0.0% | +112.6% |
| 2019.12 | 2019/08/13 | Q2予 | 3,038 | → | 0.0% | +145.0% | 313 | → | 0.0% | +118.9% | 279 | → | 0.0% | +116.7% | 214 | → | 0.0% | +112.6% |
| 2019.12 | 2019/06/25 | 修正予 | 3,038 | ↑ | +145.0% | +145.0% | 313 | ↑ | +118.9% | +118.9% | 279 | ↑ | +116.8% | +116.7% | 214 | ↑ | +112.6% | +112.6% |
| 2019.12 | 2019/05/13 | Q1予 | 1,240 | → | 0.0% | 0.0% | -1,658 | → | 0.0% | 0.0% | -1,658 | ↑ | +0.8% | +0.8% | -1,693 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/08 | 当初予 | 1,240 | - | - | - | -1,658 | - | - | - | -1,671 | - | - | - | -1,693 | - | - | - |
| 2018.12 | 2019/02/08 | 実 | 754 | ↑ | +0.1% | -36.6% | -1,144 | ↓ | -0.7% | -68.5% | -1,159 | ↓ | -0.6% | -70.7% | -1,210 | ↓ | -0.5% | -59.6% |
| 2018.12 | 2018/12/20 | 修正予 | 753 | ↓ | -36.7% | -36.7% | -1,136 | ↓ | -67.3% | -67.3% | -1,152 | ↓ | -66.0% | -69.7% | -1,204 | ↓ | -58.8% | -58.8% |
| 2018.12 | 2018/11/09 | Q3予 | 1,190 | → | 0.0% | 0.0% | -679 | → | 0.0% | 0.0% | -694 | → | 0.0% | -2.2% | -758 | → | 0.0% | 0.0% |
| 2018.12 | 2018/08/06 | Q2予 | 1,190 | → | 0.0% | 0.0% | -679 | → | 0.0% | 0.0% | -694 | → | 0.0% | -2.2% | -758 | → | 0.0% | 0.0% |
| 2018.12 | 2018/05/11 | Q1予 | 1,190 | → | 0.0% | 0.0% | - | - | - | - | -694 | ↓ | -2.2% | -2.2% | -758 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/09 | 当初予 | 1,190 | - | - | - | -679 | - | - | - | -679 | - | - | - | -758 | - | - | - |
| 2017.12 | 2018/02/09 | 実 | 657 | ↓ | -6.3% | -54.4% | -699 | ↑ | +3.9% | -1892.3% | -711 | ↑ | +3.7% | -1923.1% | -737 | ↑ | +3.8% | -12383.3% |
| 2017.12 | 2017/11/10 | Q3予 | 701 | ↓ | -51.3% | -51.3% | -727 | ↓ | -1964.1% | -1964.1% | -738 | ↓ | -2208.6% | -1992.3% | -766 | ↓ | -12866.7% | -12866.7% |
| 2017.12 | 2017/08/07 | Q2予 | 1,440 | → | 0.0% | 0.0% | 39 | → | 0.0% | 0.0% | 35 | ↓ | -10.3% | -10.3% | 6 | → | 0.0% | 0.0% |
| 2017.12 | 2017/05/12 | Q1予 | 1,440 | → | 0.0% | 0.0% | 39 | → | 0.0% | 0.0% | 39 | → | 0.0% | 0.0% | 6 | → | 0.0% | 0.0% |
| 2017.12 | 2017/02/10 | 当初予 | 1,440 | - | - | - | 39 | - | - | - | 39 | - | - | - | 6 | - | - | - |
| 2016.12 | 2017/02/10 | 実 | 811 | ↑ | +0.9% | +0.9% | -423 | ↑ | +2.1% | +2.1% | -440 | ↑ | +2.0% | +2.0% | -289 | ↑ | +3.3% | +3.3% |
| 2016.12 | 2016/12/16 | 当初予 | 804 | - | - | - | -432 | - | - | - | -449 | - | - | - | -299 | - | - | - |
| 2015.12 | 2016/02/12 | 実 | 1,569 | ↑ | +2.4% | +2.4% | 472 | ↑ | +26.9% | +26.9% | 492 | ↑ | +24.6% | +24.6% | 456 | ↑ | +25.3% | +25.3% |
| 2015.12 | 2015/11/06 | Q3予 | 1,532 | → | 0.0% | 0.0% | 372 | → | 0.0% | 0.0% | 395 | → | 0.0% | 0.0% | 364 | → | 0.0% | 0.0% |
| 2015.12 | 2015/08/07 | Q2予 | 1,532 | → | 0.0% | 0.0% | 372 | → | 0.0% | 0.0% | 395 | → | 0.0% | 0.0% | 364 | → | 0.0% | 0.0% |
| 2015.12 | 2015/07/28 | 当初予 | 1,532 | - | - | - | 372 | - | - | - | 395 | - | - | - | 364 | - | - | - |
| 2014.12 | 2015/02/13 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2014.12 | 2014/12/19 | 当初予 | 610 | - | - | - | -640 | - | - | - | -613 | - | - | - | -853 | - | - | - |
| 2013.12 | 2014/02/07 | 実 | 771 | - | - | - | -300 | - | - | - | -276 | - | - | - | -282 | - | - | - |
